nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0844	0.248	CbGbCtD
Lurasidone—CYP3A4—Triamcinolone—ankylosing spondylitis	0.064	0.188	CbGbCtD
Lurasidone—CYP3A4—Betamethasone—ankylosing spondylitis	0.0549	0.161	CbGbCtD
Lurasidone—CYP3A4—Prednisolone—ankylosing spondylitis	0.0542	0.159	CbGbCtD
Lurasidone—CYP3A4—Prednisone—ankylosing spondylitis	0.0512	0.15	CbGbCtD
Lurasidone—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0319	0.0938	CbGbCtD
Lurasidone—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00241	0.00365	CcSEcCtD
Lurasidone—Lethargy—Methotrexate—ankylosing spondylitis	0.00239	0.00363	CcSEcCtD
Lurasidone—Cerebrovascular accident—Methotrexate—ankylosing spondylitis	0.00239	0.00363	CcSEcCtD
Lurasidone—Arrhythmia—Prednisolone—ankylosing spondylitis	0.00239	0.00362	CcSEcCtD
Lurasidone—Osteoarthritis—Methotrexate—ankylosing spondylitis	0.00234	0.00355	CcSEcCtD
Lurasidone—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.00229	0.00347	CcSEcCtD
Lurasidone—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00227	0.00345	CcSEcCtD
Lurasidone—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00227	0.00344	CcSEcCtD
Lurasidone—Bradycardia—Betamethasone—ankylosing spondylitis	0.00227	0.00344	CcSEcCtD
Lurasidone—Neutropenia—Prednisone—ankylosing spondylitis	0.00227	0.00344	CcSEcCtD
Lurasidone—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.00223	0.00339	CcSEcCtD
Lurasidone—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00222	0.00337	CcSEcCtD
Lurasidone—Weight increased—Prednisone—ankylosing spondylitis	0.00221	0.00335	CcSEcCtD
Lurasidone—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00219	0.00333	CcSEcCtD
Lurasidone—Vision blurred—Prednisolone—ankylosing spondylitis	0.00219	0.00332	CcSEcCtD
Lurasidone—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00219	0.00332	CcSEcCtD
Lurasidone—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.00219	0.00332	CcSEcCtD
Lurasidone—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00215	0.00326	CcSEcCtD
Lurasidone—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00213	0.00323	CcSEcCtD
Lurasidone—Angioedema—Prednisolone—ankylosing spondylitis	0.00212	0.00322	CcSEcCtD
Lurasidone—Breast disorder—Methotrexate—ankylosing spondylitis	0.00212	0.00321	CcSEcCtD
Lurasidone—Malaise—Prednisolone—ankylosing spondylitis	0.0021	0.00318	CcSEcCtD
Lurasidone—Vertigo—Prednisolone—ankylosing spondylitis	0.00209	0.00317	CcSEcCtD
Lurasidone—Syncope—Prednisolone—ankylosing spondylitis	0.00208	0.00316	CcSEcCtD
Lurasidone—Eye disorder—Betamethasone—ankylosing spondylitis	0.00208	0.00316	CcSEcCtD
Lurasidone—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00208	0.00316	CcSEcCtD
Lurasidone—Back pain—Triamcinolone—ankylosing spondylitis	0.00207	0.00314	CcSEcCtD
Lurasidone—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00204	0.0031	CcSEcCtD
Lurasidone—Angiopathy—Betamethasone—ankylosing spondylitis	0.00202	0.00307	CcSEcCtD
Lurasidone—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00202	0.00307	CcSEcCtD
Lurasidone—Convulsion—Prednisolone—ankylosing spondylitis	0.00201	0.00305	CcSEcCtD
Lurasidone—Hypertension—Prednisolone—ankylosing spondylitis	0.00201	0.00304	CcSEcCtD
Lurasidone—Eosinophilia—Methotrexate—ankylosing spondylitis	0.00201	0.00304	CcSEcCtD
Lurasidone—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00199	0.00302	CcSEcCtD
Lurasidone—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00199	0.00302	CcSEcCtD
Lurasidone—Bradycardia—Prednisone—ankylosing spondylitis	0.00198	0.003	CcSEcCtD
Lurasidone—Angioedema—Triamcinolone—ankylosing spondylitis	0.00195	0.00296	CcSEcCtD
Lurasidone—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00195	0.00296	CcSEcCtD
Lurasidone—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00194	0.00295	CcSEcCtD
Lurasidone—Malaise—Triamcinolone—ankylosing spondylitis	0.00193	0.00292	CcSEcCtD
Lurasidone—Malaise—Methylprednisolone—ankylosing spondylitis	0.00192	0.00292	CcSEcCtD
Lurasidone—Vertigo—Triamcinolone—ankylosing spondylitis	0.00192	0.00291	CcSEcCtD
Lurasidone—Syncope—Triamcinolone—ankylosing spondylitis	0.00192	0.00291	CcSEcCtD
Lurasidone—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00192	0.00291	CcSEcCtD
Lurasidone—Syncope—Methylprednisolone—ankylosing spondylitis	0.00191	0.0029	CcSEcCtD
Lurasidone—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00191	0.00289	CcSEcCtD
Lurasidone—Dysuria—Methotrexate—ankylosing spondylitis	0.00189	0.00287	CcSEcCtD
Lurasidone—Neutropenia—Methotrexate—ankylosing spondylitis	0.00189	0.00287	CcSEcCtD
Lurasidone—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00188	0.00285	CcSEcCtD
Lurasidone—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00187	0.00284	CcSEcCtD
Lurasidone—Shock—Prednisolone—ankylosing spondylitis	0.00187	0.00283	CcSEcCtD
Lurasidone—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00187	0.00283	CcSEcCtD
Lurasidone—Convulsion—Triamcinolone—ankylosing spondylitis	0.00185	0.00281	CcSEcCtD
Lurasidone—Tachycardia—Prednisolone—ankylosing spondylitis	0.00185	0.00281	CcSEcCtD
Lurasidone—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00185	0.0028	CcSEcCtD
Lurasidone—Hypertension—Triamcinolone—ankylosing spondylitis	0.00185	0.0028	CcSEcCtD
Lurasidone—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00184	0.00279	CcSEcCtD
Lurasidone—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00183	0.00278	CcSEcCtD
Lurasidone—Myalgia—Triamcinolone—ankylosing spondylitis	0.00182	0.00276	CcSEcCtD
Lurasidone—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00182	0.00275	CcSEcCtD
Lurasidone—Eye disorder—Prednisone—ankylosing spondylitis	0.00181	0.00275	CcSEcCtD
Lurasidone—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00181	0.00274	CcSEcCtD
Lurasidone—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00181	0.00274	CcSEcCtD
Lurasidone—Infestation—Methotrexate—ankylosing spondylitis	0.00181	0.00274	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.0018	0.00273	CcSEcCtD
Lurasidone—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00178	0.0027	CcSEcCtD
Lurasidone—Renal failure—Methotrexate—ankylosing spondylitis	0.00178	0.00269	CcSEcCtD
Lurasidone—Angioedema—Dexamethasone—ankylosing spondylitis	0.00177	0.00269	CcSEcCtD
Lurasidone—Angioedema—Betamethasone—ankylosing spondylitis	0.00177	0.00269	CcSEcCtD
Lurasidone—Angiopathy—Prednisone—ankylosing spondylitis	0.00176	0.00267	CcSEcCtD
Lurasidone—Malaise—Dexamethasone—ankylosing spondylitis	0.00175	0.00265	CcSEcCtD
Lurasidone—Malaise—Betamethasone—ankylosing spondylitis	0.00175	0.00265	CcSEcCtD
Lurasidone—Vertigo—Betamethasone—ankylosing spondylitis	0.00174	0.00264	CcSEcCtD
Lurasidone—Vertigo—Dexamethasone—ankylosing spondylitis	0.00174	0.00264	CcSEcCtD
Lurasidone—Syncope—Dexamethasone—ankylosing spondylitis	0.00174	0.00264	CcSEcCtD
Lurasidone—Syncope—Betamethasone—ankylosing spondylitis	0.00174	0.00264	CcSEcCtD
Lurasidone—Arrhythmia—Prednisone—ankylosing spondylitis	0.00173	0.00263	CcSEcCtD
Lurasidone—Infection—Triamcinolone—ankylosing spondylitis	0.00173	0.00263	CcSEcCtD
Lurasidone—Infection—Methylprednisolone—ankylosing spondylitis	0.00173	0.00262	CcSEcCtD
Lurasidone—Shock—Triamcinolone—ankylosing spondylitis	0.00172	0.0026	CcSEcCtD
Lurasidone—Insomnia—Prednisolone—ankylosing spondylitis	0.00172	0.0026	CcSEcCtD
Lurasidone—Shock—Methylprednisolone—ankylosing spondylitis	0.00171	0.0026	CcSEcCtD
Lurasidone—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00171	0.00259	CcSEcCtD
Lurasidone—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00171	0.00259	CcSEcCtD
Lurasidone—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.0017	0.00259	CcSEcCtD
Lurasidone—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.0017	0.00259	CcSEcCtD
Lurasidone—Tachycardia—Triamcinolone—ankylosing spondylitis	0.0017	0.00258	CcSEcCtD
Lurasidone—Mental disorder—Prednisone—ankylosing spondylitis	0.0017	0.00258	CcSEcCtD
Lurasidone—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.0017	0.00258	CcSEcCtD
Lurasidone—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00169	0.00256	CcSEcCtD
Lurasidone—Malnutrition—Prednisone—ankylosing spondylitis	0.00169	0.00256	CcSEcCtD
Lurasidone—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00169	0.00256	CcSEcCtD
Lurasidone—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00169	0.00256	CcSEcCtD
Lurasidone—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00168	0.00255	CcSEcCtD
Lurasidone—Convulsion—Betamethasone—ankylosing spondylitis	0.00168	0.00255	CcSEcCtD
Lurasidone—Convulsion—Dexamethasone—ankylosing spondylitis	0.00168	0.00255	CcSEcCtD
Lurasidone—Hypertension—Betamethasone—ankylosing spondylitis	0.00167	0.00254	CcSEcCtD
Lurasidone—Hypertension—Dexamethasone—ankylosing spondylitis	0.00167	0.00254	CcSEcCtD
Lurasidone—Myalgia—Dexamethasone—ankylosing spondylitis	0.00165	0.0025	CcSEcCtD
Lurasidone—Myalgia—Betamethasone—ankylosing spondylitis	0.00165	0.0025	CcSEcCtD
Lurasidone—Anxiety—Dexamethasone—ankylosing spondylitis	0.00165	0.0025	CcSEcCtD
Lurasidone—Anxiety—Betamethasone—ankylosing spondylitis	0.00165	0.0025	CcSEcCtD
Lurasidone—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00163	0.00247	CcSEcCtD
Lurasidone—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.0016	0.00243	CcSEcCtD
Lurasidone—Vision blurred—Prednisone—ankylosing spondylitis	0.00159	0.00241	CcSEcCtD
Lurasidone—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00159	0.00241	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00159	0.00241	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00159	0.00241	CcSEcCtD
Lurasidone—Insomnia—Triamcinolone—ankylosing spondylitis	0.00158	0.00239	CcSEcCtD
Lurasidone—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00157	0.00239	CcSEcCtD
Lurasidone—Infection—Dexamethasone—ankylosing spondylitis	0.00157	0.00238	CcSEcCtD
Lurasidone—Infection—Betamethasone—ankylosing spondylitis	0.00157	0.00238	CcSEcCtD
Lurasidone—Anaemia—Prednisone—ankylosing spondylitis	0.00156	0.00237	CcSEcCtD
Lurasidone—Shock—Dexamethasone—ankylosing spondylitis	0.00156	0.00236	CcSEcCtD
Lurasidone—Shock—Betamethasone—ankylosing spondylitis	0.00156	0.00236	CcSEcCtD
Lurasidone—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00156	0.00236	CcSEcCtD
Lurasidone—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00155	0.00235	CcSEcCtD
Lurasidone—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00155	0.00235	CcSEcCtD
Lurasidone—Agitation—Prednisone—ankylosing spondylitis	0.00155	0.00235	CcSEcCtD
Lurasidone—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00154	0.00234	CcSEcCtD
Lurasidone—Tachycardia—Betamethasone—ankylosing spondylitis	0.00154	0.00234	CcSEcCtD
Lurasidone—Angioedema—Prednisone—ankylosing spondylitis	0.00154	0.00234	CcSEcCtD
Lurasidone—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00154	0.00233	CcSEcCtD
Lurasidone—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00153	0.00232	CcSEcCtD
Lurasidone—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00153	0.00232	CcSEcCtD
Lurasidone—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00153	0.00232	CcSEcCtD
Lurasidone—Malaise—Prednisone—ankylosing spondylitis	0.00152	0.00231	CcSEcCtD
Lurasidone—Vertigo—Prednisone—ankylosing spondylitis	0.00152	0.0023	CcSEcCtD
Lurasidone—Eye disorder—Methotrexate—ankylosing spondylitis	0.00152	0.0023	CcSEcCtD
Lurasidone—Syncope—Prednisone—ankylosing spondylitis	0.00151	0.0023	CcSEcCtD
Lurasidone—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.0015	0.00228	CcSEcCtD
Lurasidone—Fatigue—Triamcinolone—ankylosing spondylitis	0.0015	0.00228	CcSEcCtD
Lurasidone—Fatigue—Methylprednisolone—ankylosing spondylitis	0.0015	0.00228	CcSEcCtD
Lurasidone—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00148	0.00225	CcSEcCtD
Lurasidone—Hypotension—Betamethasone—ankylosing spondylitis	0.00148	0.00224	CcSEcCtD
Lurasidone—Hypotension—Dexamethasone—ankylosing spondylitis	0.00148	0.00224	CcSEcCtD
Lurasidone—Angiopathy—Methotrexate—ankylosing spondylitis	0.00147	0.00223	CcSEcCtD
Lurasidone—Convulsion—Prednisone—ankylosing spondylitis	0.00146	0.00222	CcSEcCtD
Lurasidone—Hypertension—Prednisone—ankylosing spondylitis	0.00146	0.00221	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00144	0.00219	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00144	0.00219	CcSEcCtD
Lurasidone—Myalgia—Prednisone—ankylosing spondylitis	0.00144	0.00218	CcSEcCtD
Lurasidone—Anxiety—Prednisone—ankylosing spondylitis	0.00143	0.00217	CcSEcCtD
Lurasidone—Insomnia—Dexamethasone—ankylosing spondylitis	0.00143	0.00217	CcSEcCtD
Lurasidone—Insomnia—Betamethasone—ankylosing spondylitis	0.00143	0.00217	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00143	0.00217	CcSEcCtD
Lurasidone—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00142	0.00216	CcSEcCtD
Lurasidone—Mental disorder—Methotrexate—ankylosing spondylitis	0.00142	0.00215	CcSEcCtD
Lurasidone—Malnutrition—Methotrexate—ankylosing spondylitis	0.00141	0.00214	CcSEcCtD
Lurasidone—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00139	0.00211	CcSEcCtD
Lurasidone—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00139	0.00211	CcSEcCtD
Lurasidone—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00138	0.00209	CcSEcCtD
Lurasidone—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00138	0.00209	CcSEcCtD
Lurasidone—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00138	0.00209	CcSEcCtD
Lurasidone—Infection—Prednisone—ankylosing spondylitis	0.00137	0.00208	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00137	0.00207	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00137	0.00207	CcSEcCtD
Lurasidone—Back pain—Methotrexate—ankylosing spondylitis	0.00137	0.00207	CcSEcCtD
Lurasidone—Fatigue—Dexamethasone—ankylosing spondylitis	0.00136	0.00207	CcSEcCtD
Lurasidone—Fatigue—Betamethasone—ankylosing spondylitis	0.00136	0.00207	CcSEcCtD
Lurasidone—Shock—Prednisone—ankylosing spondylitis	0.00136	0.00206	CcSEcCtD
Lurasidone—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00135	0.00205	CcSEcCtD
Lurasidone—Tachycardia—Prednisone—ankylosing spondylitis	0.00135	0.00204	CcSEcCtD
Lurasidone—Skin disorder—Prednisone—ankylosing spondylitis	0.00134	0.00203	CcSEcCtD
Lurasidone—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00133	0.00202	CcSEcCtD
Lurasidone—Vision blurred—Methotrexate—ankylosing spondylitis	0.00133	0.00202	CcSEcCtD
Lurasidone—Anaemia—Methotrexate—ankylosing spondylitis	0.0013	0.00198	CcSEcCtD
Lurasidone—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00129	0.00196	CcSEcCtD
Lurasidone—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00129	0.00196	CcSEcCtD
Lurasidone—Malaise—Methotrexate—ankylosing spondylitis	0.00127	0.00193	CcSEcCtD
Lurasidone—Vertigo—Methotrexate—ankylosing spondylitis	0.00127	0.00192	CcSEcCtD
Lurasidone—Leukopenia—Methotrexate—ankylosing spondylitis	0.00126	0.00192	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00126	0.0019	CcSEcCtD
Lurasidone—Dizziness—Prednisolone—ankylosing spondylitis	0.00125	0.0019	CcSEcCtD
Lurasidone—Asthenia—Triamcinolone—ankylosing spondylitis	0.00125	0.0019	CcSEcCtD
Lurasidone—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00125	0.0019	CcSEcCtD
Lurasidone—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00125	0.0019	CcSEcCtD
Lurasidone—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00125	0.00189	CcSEcCtD
Lurasidone—Insomnia—Prednisone—ankylosing spondylitis	0.00125	0.00189	CcSEcCtD
Lurasidone—Pruritus—Triamcinolone—ankylosing spondylitis	0.00123	0.00187	CcSEcCtD
Lurasidone—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00123	0.00187	CcSEcCtD
Lurasidone—Convulsion—Methotrexate—ankylosing spondylitis	0.00122	0.00185	CcSEcCtD
Lurasidone—Dyspepsia—Prednisone—ankylosing spondylitis	0.00121	0.00184	CcSEcCtD
Lurasidone—Myalgia—Methotrexate—ankylosing spondylitis	0.0012	0.00182	CcSEcCtD
Lurasidone—Decreased appetite—Prednisone—ankylosing spondylitis	0.0012	0.00182	CcSEcCtD
Lurasidone—Rash—Prednisolone—ankylosing spondylitis	0.0012	0.00181	CcSEcCtD
Lurasidone—Dermatitis—Prednisolone—ankylosing spondylitis	0.00119	0.00181	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00119	0.00181	CcSEcCtD
Lurasidone—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00119	0.00181	CcSEcCtD
Lurasidone—Fatigue—Prednisone—ankylosing spondylitis	0.00119	0.0018	CcSEcCtD
Lurasidone—Dizziness—Triamcinolone—ankylosing spondylitis	0.00115	0.00175	CcSEcCtD
Lurasidone—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00115	0.00175	CcSEcCtD
Lurasidone—Infection—Methotrexate—ankylosing spondylitis	0.00114	0.00174	CcSEcCtD
Lurasidone—Asthenia—Dexamethasone—ankylosing spondylitis	0.00114	0.00172	CcSEcCtD
Lurasidone—Asthenia—Betamethasone—ankylosing spondylitis	0.00114	0.00172	CcSEcCtD
Lurasidone—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00113	0.00171	CcSEcCtD
Lurasidone—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00113	0.00171	CcSEcCtD
Lurasidone—Nausea—Prednisolone—ankylosing spondylitis	0.00113	0.00171	CcSEcCtD
Lurasidone—Pruritus—Dexamethasone—ankylosing spondylitis	0.00112	0.0017	CcSEcCtD
Lurasidone—Pruritus—Betamethasone—ankylosing spondylitis	0.00112	0.0017	CcSEcCtD
Lurasidone—Skin disorder—Methotrexate—ankylosing spondylitis	0.00112	0.0017	CcSEcCtD
Lurasidone—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00111	0.00169	CcSEcCtD
Lurasidone—Vomiting—Triamcinolone—ankylosing spondylitis	0.00111	0.00168	CcSEcCtD
Lurasidone—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00111	0.00168	CcSEcCtD
Lurasidone—Rash—Triamcinolone—ankylosing spondylitis	0.0011	0.00167	CcSEcCtD
Lurasidone—Dermatitis—Triamcinolone—ankylosing spondylitis	0.0011	0.00167	CcSEcCtD
Lurasidone—Rash—Methylprednisolone—ankylosing spondylitis	0.0011	0.00166	CcSEcCtD
Lurasidone—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.0011	0.00166	CcSEcCtD
Lurasidone—Abdominal pain—Prednisone—ankylosing spondylitis	0.00109	0.00165	CcSEcCtD
Lurasidone—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00108	0.00164	CcSEcCtD
Lurasidone—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00108	0.00164	CcSEcCtD
Lurasidone—Hypotension—Methotrexate—ankylosing spondylitis	0.00108	0.00163	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00105	0.00159	CcSEcCtD
Lurasidone—Dizziness—Betamethasone—ankylosing spondylitis	0.00105	0.00159	CcSEcCtD
Lurasidone—Dizziness—Dexamethasone—ankylosing spondylitis	0.00105	0.00159	CcSEcCtD
Lurasidone—Insomnia—Methotrexate—ankylosing spondylitis	0.00104	0.00158	CcSEcCtD
Lurasidone—Nausea—Triamcinolone—ankylosing spondylitis	0.00104	0.00157	CcSEcCtD
Lurasidone—Nausea—Methylprednisolone—ankylosing spondylitis	0.00103	0.00157	CcSEcCtD
Lurasidone—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00103	0.00156	CcSEcCtD
Lurasidone—Somnolence—Methotrexate—ankylosing spondylitis	0.00102	0.00155	CcSEcCtD
Lurasidone—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00101	0.00154	CcSEcCtD
Lurasidone—Vomiting—Betamethasone—ankylosing spondylitis	0.00101	0.00153	CcSEcCtD
Lurasidone—Vomiting—Dexamethasone—ankylosing spondylitis	0.00101	0.00153	CcSEcCtD
Lurasidone—Decreased appetite—Methotrexate—ankylosing spondylitis	0.001	0.00152	CcSEcCtD
Lurasidone—Rash—Dexamethasone—ankylosing spondylitis	0.000998	0.00151	CcSEcCtD
Lurasidone—Rash—Betamethasone—ankylosing spondylitis	0.000998	0.00151	CcSEcCtD
Lurasidone—Dermatitis—Betamethasone—ankylosing spondylitis	0.000997	0.00151	CcSEcCtD
Lurasidone—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000997	0.00151	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000995	0.00151	CcSEcCtD
Lurasidone—Fatigue—Methotrexate—ankylosing spondylitis	0.000993	0.00151	CcSEcCtD
Lurasidone—Asthenia—Prednisone—ankylosing spondylitis	0.000989	0.0015	CcSEcCtD
Lurasidone—Pruritus—Prednisone—ankylosing spondylitis	0.000975	0.00148	CcSEcCtD
Lurasidone—Diarrhoea—Prednisone—ankylosing spondylitis	0.000943	0.00143	CcSEcCtD
Lurasidone—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000942	0.00143	CcSEcCtD
Lurasidone—Nausea—Betamethasone—ankylosing spondylitis	0.00094	0.00143	CcSEcCtD
Lurasidone—Nausea—Dexamethasone—ankylosing spondylitis	0.00094	0.00143	CcSEcCtD
Lurasidone—Dizziness—Prednisone—ankylosing spondylitis	0.000912	0.00138	CcSEcCtD
Lurasidone—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000911	0.00138	CcSEcCtD
Lurasidone—Vomiting—Prednisone—ankylosing spondylitis	0.000876	0.00133	CcSEcCtD
Lurasidone—Rash—Prednisone—ankylosing spondylitis	0.000869	0.00132	CcSEcCtD
Lurasidone—Dermatitis—Prednisone—ankylosing spondylitis	0.000868	0.00132	CcSEcCtD
Lurasidone—Asthenia—Methotrexate—ankylosing spondylitis	0.000827	0.00125	CcSEcCtD
Lurasidone—Nausea—Prednisone—ankylosing spondylitis	0.000819	0.00124	CcSEcCtD
Lurasidone—Pruritus—Methotrexate—ankylosing spondylitis	0.000815	0.00124	CcSEcCtD
Lurasidone—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000788	0.0012	CcSEcCtD
Lurasidone—Dizziness—Methotrexate—ankylosing spondylitis	0.000762	0.00116	CcSEcCtD
Lurasidone—Vomiting—Methotrexate—ankylosing spondylitis	0.000732	0.00111	CcSEcCtD
Lurasidone—Rash—Methotrexate—ankylosing spondylitis	0.000726	0.0011	CcSEcCtD
Lurasidone—Dermatitis—Methotrexate—ankylosing spondylitis	0.000726	0.0011	CcSEcCtD
Lurasidone—Nausea—Methotrexate—ankylosing spondylitis	0.000684	0.00104	CcSEcCtD
